Could Opioid-Free pain relief be safer for kids with sleep apnea?
NCT ID NCT07435493
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares standard fentanyl pain medicine to an opioid-free mix of acetaminophen, ibuprofen, ketamine, and dexamethasone in 64 children aged 5-10 with mild to moderate sleep apnea undergoing tonsil surgery. The goal is to see if the opioid-free option controls pain just as well but with fewer breathing problems and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fentanyl, acetaminophen, ibuprofen, ketamine, dexamethasone
- What this could lead to
- If successful, this could show that a combination of non-opioid drugs can control pain safely in children with sleep apnea, reducing breathing complications.
- What could go wrong
- This is a small, early-stage trial with only 64 children, so results may not apply to all. The opioid-free approach might not control pain as well as fentanyl.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOTONSILLECTOMY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ain shams university
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a home sleep test beat the hospital for diagnosing apnea?
- A dual sleep disorder: can one pill boost CPAP success?
- What lies beneath sleep apnea? a deep dive into its hidden health ties
- Can a simple questionnaire spot hidden sleep apnea in millions?
- Wall squats tested as a blood pressure hack for sleep apnea patients
- Could a diabetes drug curb opioid addiction? a trial puts semaglutide to the test